A New Long Acting Insulin for Diabetic Patients

The patients of type-2 diabetes would soon get a new long acting insulin shot. The new form of insulin would be given to the patents thrice-a-week rather than every day. The new insulin would be a breakthrough for the patients of type-2 diabetes. The body of these patients does not produce enough insulin which is required for the body to be able to use glucose for energy. The insulin injections are given to them so that their blood sugar level could be kept low. The newly developed insulin shot works for 48 hours and is as good in controlling the insulin as the once-a-day shot. The new form of long acting insulin, Degludec has been jointly tested by doctors from India, Canada, US and South Africa. The clinical trials of the new form of insulin suggest that it might help in reducing the risk of hypoglycemia.

Medicamentos podem substituir cirurgia na diabetes

Fonte: aqui.

For people with Type 2 diabetes and stable heart disease, drug treatments are as effective as angioplasty or bypass surgery in some cases, a new study suggests. It's an important issue given that adults with Type 2 diabetes are two to four times more likely to develop heart disease, and heart attacks and strokes are more likely to be fatal, the researchers said. When doctors decide angioplasty and a stent (a wire mesh scaffold that props open an artery) are needed to restore blood flow and reduce chest pain, the latest results suggest it's safe to use drug treatments. But for people with extensive coronary artery disease, getting invasive bypass surgery right away may help to prevent a future heart attack.